E-cadherin usually sequesters β-catenin at sites of cell–cell contacts; decreased E-cadherin expression during EMT leads to nuclear translocation of β-catenin and activation of WNT/β-catenin signaling, shown to be a relevant pathway in tumor budding in CRC patients [89]. Here, CDH1 is linked to neoplasm.